Posted on October 22nd, 2012 by
Class: Biological therapy
Generic Name: Regorafenib
Trade Name: Stivarga®
How is this drug used? Stivarga is used to treat patients with metastatic colorectal cancer that has previously been treated with certain types of chemotherapy and other medications.
What is the mechanism of action? Stivarga is a type of drug known as a multi-kinase inhibitor. It blocks several enzymes that play a role in cancer growth.
How is Stivarga given (administered)? Stivarga comes in tablet form and is taken orally (by mouth).
How are patients monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with Stivarga. Blood will be drawn to monitor functions of some organ systems, such as the liver. Patients may also undergo physical examinations, scans or other measures to assess side effects and response to therapy.
What are the most common side effects of treatment with Stivarga?
What are some of the potentially serious side effects of treatment with Stivarga?
This is not a complete list of side effects. Some patients may experience other side effects that are not listed here. Patients may wish to discuss with their physician the other less common side effects of this drug, some of which may be serious.
Some side effects may require medical attention. Other side effects do not require medical attention and may go away during treatment. Patients should check with their physician about any side effects that continue or are bothersome.
What can patients do to help alleviate or prevent discomfort and side effects?
Are there any special precautions patients should be aware of before starting treatment?
When should patients notify their physician?
Tell your doctor if you experience any side effects that bother you or don’t go away. Also tell your doctor if you experience signs of liver problems (such as yellowing of the skin or the whites of the eyes, nausea or vomiting, dark urine, or changes in sleep pattern), signs of bleeding problems (such as vomiting blood, vomit that looks like coffee grounds, pink or brown urine, red or tarry stools, coughing up blood or blood clots, heavier-than-usual menstrual bleeding, unusual vaginal bleeds, or frequent nose bleeds), signs of skin problems (such as redness, pain, blisters, bleeding, or swelling on the palms of the hands or soles of the feet, or a rash), signs of severe high blood pressure (such as severe headaches, lightheadedness, or changes in vision), signs of heart problems (such as chest pain, shortness of breath, dizziness, or feeling like you’re going pass out; contact emergency help), signs of Reversible Posterior Leukoencephalopathy Syndrome (such as severe headaches, seizure, confusion, or change in vision), or signs of a tear in the gastrointestinal tract (such as severe pain in the abdomen, swelling in the abdomen, or a high fever).
What is a package insert?
A package insert is required by the FDA and contains a summary of the essential scientific information needed for the safe and effective use of the drug for healthcare providers and consumers. A package insert typically includes information regarding specific indications, administration schedules, dosing, side effects, contraindications, results from some clinical trials, chemical structure, pharmacokinetics and metabolism of the specific drug. By carefully reviewing the package insert, you will get the most complete and current information about how to safely use this drug. If you do not have the package insert for the drug you are using, your pharmacist or physician may be able to provide you with a copy.
Copyright © 2017 CancerConnect Last updated 10/12.
Important Limitations of Use
The information provided above on the drug you have selected is provided for your information only and is not a substitute for consultation with an appropriate medical doctor. We are providing this information solely as a courtesy and, as such, it is in no way a recommendation as to the safety, efficacy or appropriateness of any particular drug, regimen, dosing schedule for any particular cancer, condition or patient nor is it in any way to be considered medical advice. Patients should discuss the appropriateness of a particular drug or chemotherapy regimen with their physician.
As with any printed reference, the use of particular drugs, regimens and drug dosages may become out-of-date over time, since new information may have been published and become generally accepted after the latest update to this printed information. Please keep in mind that health care professionals are fully responsible for practicing within current standards, avoiding use of outdated regimens, employing good clinical judgment in selecting drugs and/or regimens, in calculating doses for individual patients, and verifying all dosage calculations.
DISCLAIMER OF WARRANTIES
CANCERCONNECT.COM SPECIFICALLY DISCLAIMS AND EXCLUDES ALL EXPRESSED OR IMPLIED WARRANTIES, INCLUDING ANY IMPLIED WARRANTIES AS TO QUALITY, ACCURACY (INCLUDING TYPOGRAPHICAL ERRORS), MERCHANTABILITY, OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE INFORMATION CONTAINED HEREIN. CANCERCONNECT.COM DISCLAIMS ALL LIABILITY OR DAMAGES ARISING FROM ANY USE OF THE INFORMATION.
The prescribing physician is solely responsible for making all decisions relating to appropriate patient care including, but not limited to, drugs, regimens, dose, schedule, and any supportive care.
You must be logged-in to the site to post a comment.